Preferred Label : ogsiveo;

Details


Main resources

You can consult :


https://ansm.sante.fr/tableau-acces-derogatoire/nirogacestat
2026
false
false
false
France
French
administration, oral
nirogacestat
ogsiveo
Desmoid Tumors
Refractory Desmoid Fibromatosis
nirogacestat
drug information
tetrahydronaphthalenes
valine

---
https://www.has-sante.fr/jcms/p_3840717/fr/ogsiveo-nirogacestat-tumeurs-desmoides
2026
false
false
false
France
technical report
ogsiveo
nirogacestat
Desmoid Tumors
adult
nirogacestat
drug information

---
https://www.has-sante.fr/jcms/p_3576525/fr/ogsiveo-nirogacestat-tumeurs-desmoides
2025
false
false
false
France
nirogacestat
treatment outcome
insurance, health, reimbursement
Tumor Progression
Refractory Desmoid Fibromatosis
adult
administration, oral
Gamma Secretase Inhibitors
nirogacestat
evaluation of the transparency committee
ogsiveo
Desmoid Tumors

---
Nous contacter.
03/02/2026


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.